oral, brain-penetrant PARP1/2 inh./DNA trap.

in Ph. III for maint. in ovarian + gastric cancer

ligand-based design from lit. PARPi

J. Med. Chem., Dec. 2, 2020

Beigene, Beijing, CN

Beigene oral, brain-penetrant PARP1/2 inhibitor/DNA trapping agent


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks